Filed Pursuant to Rule 424(b)(3)
Registration No. 333-259142
PROSPECTUS SUPPLEMENT NO. 3
To
Prospectus Dated September 8, 2021
CCC INTELLIGENT SOLUTIONS HOLDINGS INC.
569,506,621 Shares of Common Stock
21,300,000 Warrants to Purchase Common Stock
This prospectus supplement
amends and supplements the prospectus dated September 8, 2021, as supplemented or amended from time to time (Prospectus), which forms a part of our Registration Statement on Form S-1 (No. 333-259142).
This prospectus supplement is being filed to update and supplement the information in the Prospectus with the information contained in our Current Report on Form 8-K, filed with the U.S. Securities and
Exchange Commission on January 4, 2022 (the Current Report). Accordingly, we have attached the Current Report to this prospectus supplement.
The Prospectus and this prospectus supplement relate to: (1) the issuance by us of up to 35,100,000 shares of common stock, par value $0.0001
(New CCC Common Stock or Common Stock), that may be issued upon exercise of warrants to purchase Common Stock at an exercise price of $11.50 per share of Common Stock, including the Public Warrants, the Private Placement
Warrants and the Forward Purchase Warrants (each as defined below); and (2) the offer and sale, from time to time, by the selling holders identified in this prospectus (the Selling Holders), or their permitted transferees, of
(i) up to 569,506,621 shares of Common Stock and (ii) up to 21,300,000 Private Placement Warrants and Forward Purchase Warrants.
The New CCC
Common Stock is listed on the New York Stock Exchange (the NYSE) under the symbol CCCS. On January 3, 2022, the last reported sales price of the New CCC Common Stock was $11.37 per share. The Public Warrants ceased
trading on the New York Stock Exchange and were delisted, with the trading halt announced after close of market on December 28, 2021. We are an emerging growth company as defined under the U.S. federal securities laws and, as such,
may elect to comply with certain reduced public company reporting requirements for this and future filings.
This prospectus supplement updates and
supplements the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement should be read in
conjunction with the Prospectus and if there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement.
Investing in our securities involve risks that are described in Risk Factors beginning on page 15 of the Prospectus.
Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or
adequacy of this prospectus. Any representation to the contrary is a criminal offense.
The date of
this prospectus supplement is January 4, 2022